How does your health technology (e.g., drug, vaccine, device, diagnostic) compare to competing alternatives in the same therapeutic area? Is it considered cost-effective? Cost-effectiveness focuses on maximizing health benefits for a given budget. It does not simply indicate the least expensive or the most effective alternative. There are 5 common scenarios where a health … [Read more...]

Digital maturity is essential for scientific engagement amid more complex therapies and spheres of influence. Nearly six in 10 life sciences products hitting the market are in specialty or rare disease categories.1 As scientific complexity grows, healthcare professionals (HCPs) and key opinion leaders (KOLs) seek science-based education via webinars, virtual medical … [Read more...]

My journey as a Medical Science Liaison began about a year ago. To give you a little background of how I transitioned into this field, let me share with you my own personal story. I want to begin by saying that I have a unique journey, and I always believe that every step we take in our life is meant to get us to wherever the next step will be. Sometimes it’s hard to see … [Read more...]

“Promotability” may be defined as one’s suitability for being promoted. Is it your goal to obtain a promotion this year? If so, how suitable or promotable are you for that next step? Job-seekers and professionals often ask me what steps are necessary for advancement. I have broken my advice down to the always popular “Top 10” List. However, there is one VERY important concept … [Read more...]

The MSL role has become more strategic as the frontline agent for KOL engagement.  KOL expectations have also increased in terms of what they are looking for from biopharma partnerships.  The trend toward personalized engagement has accelerated significantly due to rapid digital transformation and hybrid engagement advancements in recent years across life science companies.   … [Read more...]